Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

12 September 1997

Tilapia Brockman Bnodiesa: inexpensive, simple model for discordant islet xenotransplantation

James R Wright, Hua Yang

Ann Transplant 1997; 2(3): 72-76 :: ID: 497270

Abstract

Brockmann bodies (BBs). large anatomically discrete islet organs found in some teleost fish. are much more easily harvested than pancreatic islets from mammalian donor sources. Tilapia islets, when transplanted into streptozotocin-diabetic athymic nude mice, will produce long-term normoglycemia and mammalian-like glucose tolerance profiles. Our laboratory has used tilapia BBs as an inexpensive model for studying islet xenograft rejection between discordant species. When transplanted into immunocompetent diabetic mice, tilapia BBs reject in roughly 7-8 days. Results to date suggest that tilapia islets are very immunogenic and that encapsulation is necessary to achieve long-term function in euthymic recipients. Continuous, high-dose immunosuppression using IS-DSG is also effective but causes lethal bone marrow suppression. Less aggressive immunosuppression regimens have achieved only modest prolongation of mean graft survival time. Thus far, immunomodulation techniques and transplantation into immune-privileged sites have been ineffective at prolonging graft survival. Tilapia islets currently represent an excellent, inexpensive donor source for discordant islet xenotransplantation studies. In the not distant future, encapsulated islets harvested from transgenic tilapia bearing humanized tilapia insulin genes may also playa role in establishing clinical islet xenotransplantation as a useful treatment modality for type I diabetes mellitus.

Keywords: Islets of Langerhans, Xenotransplantation, discordant, teleost fish

Add Comment 0 Comments

In Press

Original article  

Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...

Ann Transplant In Press; DOI: 10.12659/AOT.951568  

Original article  

Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver Transplantation

Ann Transplant In Press; DOI: 10.12659/AOT.950589  

Database Analysis  

Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...

Ann Transplant In Press; DOI: 10.12659/AOT.950289  

Original article  

Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...

Ann Transplant In Press; DOI: 10.12659/AOT.950997  

Most Viewed Current Articles

24 Aug 2021 : Review article   18,372

Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future Perspectives

DOI :10.12659/AOT.931664

Ann Transplant 2021; 26:e931664

05 Apr 2022 : Original article   14,731

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation

DOI :10.12659/AOT.935604

Ann Transplant 2022; 27:e935604

22 Nov 2022 : Original article   14,244

Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...

DOI :10.12659/AOT.937988

Ann Transplant 2022; 27:e937988

29 Dec 2021 : Original article   13,752

Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...

DOI :10.12659/AOT.933588

Ann Transplant 2021; 26:e933588

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358